ClinicalTrials.gg
Not yet recruitingNCT07794241Updated Aug 31, 2026

Respiratory Muscle Strength and Jiu-Jitsu-Specific Performance in Male Brazilian Jiu-Jitsu Athletes

An observational study in Athletic Performance, sponsored by Halic University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-31.

Sponsored by Halic University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
40
Ages
18 Years to 40 Years
Sex
Male
01

Study summary

Brazilian Jiu-Jitsu (BJJ) is an intermittent combat sport that requires repeated high-intensity efforts and sustained gripping. This analytical cross-sectional study will examine whether respiratory muscle strength is associated with BJJ-specific anaerobic performance and static kimono grip endurance in adult male BJJ athletes. Forty athletes will attend three assessment visits separated by 48 to 72 hours. Maximal inspiratory pressure, maximal expiratory pressure, and spirometric indices (forced vital capacity [FVC], forced expiratory volume in 1 second [FEV1], FEV1/FVC ratio, and peak expiratory flow [PEF]) will be measured at the first visit. The Jiu-Jitsu Anaerobic Performance Test and the Maximum Static Kimono Grip Test will be completed at the other two visits in randomized order. The primary analysis will examine the association between maximal inspiratory pressure and the total number of valid repetitions completed during the Jiu-Jitsu Anaerobic Performance Test. Spirometric indices will be evaluated as secondary outcomes.

Read the detailed description

This is an analytical cross-sectional observational study involving 40 male Brazilian Jiu-Jitsu athletes aged 18 to 40 years. Assessments will be completed during three visits separated by 48 to 72 hours. At Visit 1, eligibility will be assessed and written informed consent will be obtained. Demographic and sport-related information, including self-reported height, body weight, and Brazilian Jiu-Jitsu experience, will be recorded. Spirometry will be performed using acceptable and repeatable forced expiratory maneuvers in accordance with current ATS/ERS technical standards. Forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), FEV1/FVC ratio, and peak expiratory flow (PEF) will be recorded; percent-predicted and z-score values will also be documented when available. Respiratory muscle strength will be assessed as maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP). Participants will perform at least five acceptable maneuvers for each pressure measurement, with up to eight attempts when necessary. The highest acceptable value meeting reproducibility criteria will be recorded in cmH2O. At Visits 2 and 3, participants will complete the Jiu-Jitsu Anaerobic Performance Test (JJAPT) and the Maximum Static Kimono Grip Test on separate days in randomized order. Before each performance test, participants will complete a standardized sport-specific warm-up. The JJAPT consists of five 60-second work bouts separated by 45 seconds of passive recovery. A partner whose body weight is within 5% of the participant's self-reported body weight will be used, and the total number of valid butterfly-guard lifting repetitions will be recorded. For the static kimono grip test, a kimono is wrapped around a horizontal bar and the participant maintains a suspended position with maximal elbow flexion for as long as possible; performance is recorded in seconds. The primary analysis will assess the relationship between MIP and JJAPT total valid repetitions. Secondary analyses will assess MEP in relation to JJAPT performance and MIP and MEP in relation to static kimono grip endurance. Spirometric indices will be summarized descriptively and examined in exploratory secondary analyses in relation to the performance outcomes. Self-reported body weight and Brazilian Jiu-Jitsu experience in months will be considered as prespecified covariates.

02

Conditions studied

  • Athletic Performance

Keywords

  • Brazilian Jiu-Jitsu
  • Respiratory Muscle Strength
  • Maximal Inspiratory Pressure
  • Maximal Expiratory Pressure
  • Anaerobic Performance
  • Kimono Grip Endurance
  • Spirometry
  • Pulmonary Function
03

In context

Lead sponsor

Halic University is the lead sponsor of 85 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adult male Brazilian Jiu-Jitsu athletes who train regularly at clubs or academies in Istanbul, Türkiye, and meet the prespecified eligibility criteria. Participants will be recruited by non-probability sampling.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male sex
  • Age 18 to 40 years
  • At least 1 year of Brazilian Jiu-Jitsu experience
  • Brazilian Jiu-Jitsu training on at least 2 days per week during the previous 3 months
  • Familiarity with gi/kimono training and the butterfly-guard lifting movement
  • Ability to safely and technically perform the Maximum Static Kimono Grip Test and the Jiu-Jitsu Anaerobic Performance Test
  • Provision of written

Exclusion criteria

Exclusion Criteria:

  • Diagnosed cardiovascular, respiratory, neurological, metabolic, or musculoskeletal condition that may affect maximal testing or participant safety
  • Active pain, acute injury, or relevant surgery during the previous 6 months
  • Current regular use of cigarettes, electronic cigarettes, or inhaled nicotine products
  • Medical advice to avoid maximal physical effort
  • Regular use of medication that may materially affect study measurements
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • Male Brazilian Jiu-Jitsu Athletes

    Adult male Brazilian Jiu-Jitsu athletes who train regularly and complete spirometric pulmonary function, respiratory muscle strength, BJJ-specific anaerobic performance, and static kimono grip endurance assessments. No intervention will be assigned.

06

What researchers measure

Primary outcomes

  1. Jiu-Jitsu Anaerobic Performance Test Total Valid Repetitions

    Total number of valid butterfly-guard lifting repetitions completed across five 60-second work bouts separated by 45 seconds of passive recovery. Higher values indicate better BJJ-specific anaerobic performance.

    Time frame: At Visit 2 or Visit 3, within 6 days after Visit 1

Secondary outcomes

  1. Maximal Inspiratory Pressure

    The highest acceptable maximal inspiratory pressure meeting prespecified reproducibility criteria, recorded in centimeters of water (cmH2O). Higher values indicate greater inspiratory muscle strength.

    Time frame: At Visit 1

  2. Maximal Expiratory Pressure

    The highest acceptable maximal expiratory pressure meeting prespecified reproducibility criteria, recorded in centimeters of water (cmH2O). Higher values indicate greater expiratory muscle strength.

    Time frame: At Visit 1

  3. Maximum Static Kimono Grip Test Time

    Maximum time, in seconds, that the participant maintains a suspended position with maximal elbow flexion while gripping a kimono wrapped around a horizontal bar. Higher values indicate greater static kimono grip endurance.

    Time frame: At Visit 2 or Visit 3, within 6 days after Visit 1

  4. Forced Vital Capacity (FVC)

    Forced vital capacity measured by spirometry and recorded in liters (L). Percent-predicted and z-score values will also be documented when available. Higher values generally indicate greater ventilatory volume, with interpretation based on appropriate reference limits.

    Time frame: At Visit 1

  5. Forced Expiratory Volume in 1 Second (FEV1)

    Forced expiratory volume in the first second measured by spirometry and recorded in liters (L). Percent-predicted and z-score values will also be documented when available. Higher values generally indicate greater expiratory volume in the first second, interpreted using appropriate reference limits.

    Time frame: At Visit 1

  6. FEV1/FVC Ratio

    Ratio of forced expiratory volume in the first second to forced vital capacity, calculated from acceptable spirometry maneuvers and recorded as a ratio and percentage. The z-score and lower limit of normal will be documented when available; lower values may indicate airflow limitation.

    Time frame: At Visit 1

  7. Peak Expiratory Flow (PEF)

    Peak expiratory flow obtained during acceptable forced spirometry maneuvers and recorded in liters per second (L/s). The highest acceptable value will be recorded. Higher values indicate greater maximal expiratory flow.

    Time frame: At Visit 1

07

Study locations

1 site
  • Roger Gracie Academy Turkey
    Istanbul, 34337, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Apr 2027, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 25, 2026
First posted
Aug 31, 2026
StartEst.
Oct 2026
Primary completionEst.
Apr 2027
CompletionEst.
Apr 2027
Last update
Aug 31, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07794241
Lead sponsor
Halic University
Responsible party
Sponsor
First posted
Aug 31, 2026
Start date
Oct 2026 (estimated)
Primary completion
Apr 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
Aug 31, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion